Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Varicella-zoster Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00920218
What this trial is testing

Safety & Immunogenicity of GlaxoSmithKline Biologicals' Herpes Zoster Vaccine 1437173A

Who this might be right for
Herpes Zoster
GlaxoSmithKline 121
Very early researchStudy completedNCT04523246
What this trial is testing

Training the Innate Immune System Against SARS-CoV-2 (COVID-19) Using the Shingrix Vaccine in Nursing Home Residents

Who this might be right for
Herpes ZosterAllergy and ImmunologyCorona Virus Infection
University of Oklahoma 217
Large-scale testing (Phase 3)Study completedNCT00985166
What this trial is testing

ProQuad in Healthy 4 to 6 Year Old Children (V221-014)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 801
Large-scale testing (Phase 3)Looking for participantsNCT06806137
What this trial is testing

A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age

Who this might be right for
Chickenpox
GlaxoSmithKline 600
Early research (Phase 1)Study completedNCT01460719
What this trial is testing

Evaluate the Safety and Immunogenicity of Inactivated Varicella-Zoster Virus (VZV) Vaccine in Adults With Hematologic Malignancies (HM) Receiving Treatment With Anti-Cluster of Differentiation (CD) 20 Monoclonal Antibodies (V212-013)

Who this might be right for
Herpes Zoster
Merck Sharp & Dohme LLC 80
Large-scale testing (Phase 3)Study completedNCT01827839
What this trial is testing

Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine GSK1437173A in Adults With a Prior Episode of Herpes Zoster

Who this might be right for
Herpes Zoster
GlaxoSmithKline 96
Large-scale testing (Phase 3)Study completedNCT01527370
What this trial is testing

Safety, Tolerability, and Immunogenicity of Zoster Vaccine Live (ZOSTAVAX™) in Healthy Adults in India (V211-025)

Who this might be right for
Herpes ZosterShingles
Merck Sharp & Dohme LLC 250
Testing effectiveness (Phase 2)Study completedNCT00092404
What this trial is testing

Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 1,210
Large-scale testing (Phase 3)Study completedNCT05150392
What this trial is testing

An Open-labelled Clinical Trial of Live Attenuated Varicella Vaccines to Evaluate the Immunity Persistence After Primary Immunization and Safety and Immunogenicity After the Booster Immunization

Who this might be right for
Varicella
Sinovac (Dalian) Vaccine Technology Co., Ltd. 1,193
Testing effectiveness (Phase 2)Looking for participantsNCT05580458
What this trial is testing

Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population

Who this might be right for
Herpes Zoster
National Institute of Allergy and Infectious Diseases (NIAID) 225
Testing effectiveness (Phase 2)Study completedNCT00353288
What this trial is testing

Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™

Who this might be right for
VaricellaRubellaMeasles+1 more
GlaxoSmithKline 446
Large-scale testing (Phase 3)Looking for participantsNCT07415252
What this trial is testing

SkyVaricella® (NBP608) Vaccine With Lower Potencies in Healthy Children Aged 12 Months to 12 Years

Who this might be right for
Varicella (Chickenpox)
SK Bioscience Co., Ltd. 780
Large-scale testing (Phase 3)Study completedNCT00969436
What this trial is testing

Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTM

Who this might be right for
VaricellaRubellaMumps+1 more
GlaxoSmithKline 450
Post-approval studies (Phase 4)Ended earlyNCT02408159
What this trial is testing

Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic Therapy

Who this might be right for
Psoriasis
Innovaderm Research Inc. 3
Not applicableNot Yet RecruitingNCT06364033
What this trial is testing

Biological and Clinical Efficacy of Shingrix in Patients With CLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaCLL-like MBL+1 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 312
Testing effectiveness (Phase 2)Active Not RecruitingNCT07311148
What this trial is testing

A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and Older

Who this might be right for
Herpes Zoster (HZ)ShinglesVZV+1 more
Guangzhou Patronus Biotech Co., Ltd. 840
Testing effectiveness (Phase 2)Study completedNCT01573182
What this trial is testing

Herpes Zoster Vaccine for Bone Marrow Transplant Donors

Who this might be right for
Herpes Zoster
University of Sydney 8
Large-scale testing (Phase 3)Study completedNCT03114943
What this trial is testing

Immunogenicity and Safety of NBP608 Compared to Varivax in Healthy Children 12 Months to 12 Years of Age

Who this might be right for
Varicella
SK Bioscience Co., Ltd. 516
Early research (Phase 1)Enrolling By InvitationNCT07633197
What this trial is testing

A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell)

Who this might be right for
Herpes
Changchun BCHT Biotechnology Co. 120
Large-scale testing (Phase 3)Study completedNCT01505647
What this trial is testing

Safety and Immunogenicity of Zoster Vaccine (ZOSTAVAX™) Made With an Alternative Manufacturing Process (AMP) (V211-042 AM1)

Who this might be right for
Herpes ZosterShingles
Merck Sharp & Dohme LLC 498
Next Page